Human Research Protections

News & Announcements

IRB Newsletter: August 2022 Edition

August 15, 2022

Topics this month:

  • BRANYplus extended through Fall 2022
  • The New IRB Initial Review Application: Launching 9/15/22
  • Did You Know?
    • About expanded access INDs
    • About IRB pre-review outreach
    • About accessing CITI
  • Ancillary Review Requirements

Read the full IRB Newsletter: August 2022 Edition

IRB Newsletter: July 2022 Edition

July 15, 2022

Topics this month:

  • HRC METS Success!
  • Reminder: Don't forget to sign up for the next ClinicalTrials.gov training
  • Did You Know?
    • If you are utilizing electronic health records...
    • We now offer consultation services
  • Upcoming Changes: New IRB review application forms for initial submissions are coming soon

Read the full IRB Newsletter: July 2022 Edition

WRG-HS Automated Withdrawal and Closure Function is Live

June 28, 2022

In the IRB’s continued efforts to streamline the IRB review process, the previously announced automated withdrawal & closure function in WRG-HS will soon be launched. Beginning the evening of June 30th, inactive submissions and applications will be auto-withdrawn or auto-closed, depending on the set of criteria detailed below. 

Specifics on the update include: 

1. Six new WRG statuses:

IRB Newsletter: June 2022 Edition

June 15, 2022

Topics this month:

  • BRANYplus extended through Summer 2022
  • BRANYplus FAQs
  • Did You Know? Conducting research supported by the Department of Defense
  • Upcoming Changes: CITI certifications to be renewed every three years
  • New Hires: Sabah Mahmud, Sr. IRB Analyst

Read the full IRB Newsletter: June 2022 Edition

BRANYplus and WCM IRB Updates

May 16, 2022

To the WCM Research Community, 

The WCM IRB began a partnership with the Biomedical Research Alliance of NY (BRANY) in December 2021 to implement BRANYplus, a temporary program to review initial submissions of proposed research studies. Due to the positive feedback on this program, BRANYplus is now being extended at least through the summer. We will provide an update on the BRANYplus end date in future communications.

IRB Newsletter: May 2023 Edition

May 15, 2022

Topics this month:

  • A New Abbreviated IRB Review Application (IRA) form is available!
  • Your Study May Need Maternal-Fetal Research Committee Approval
  • New Informed Consent Form (ICF) templates are coming!
  • HRC Team Member Spotlight: Lauren Odynocki

Read the full IRB Newsletter: May 2023 Edition

IRB Newsletter: May 2022 Edition

May 15, 2022

Topics this month:

  • The IRB website has been renovated and is now live
  • The WCM IRB will re-open to new submissions
  • Did you know? Email encryption
  • Upcoming Changes:
    • IRB meetings and submission deadlines
    • IRB determinations: Modifications required
  • New Hires: Ravji Parmar, IRB Analyst

Read the full IRB Newsletter: May 2022 Edition

IRB Newsletter: April 2022 Edition

April 22, 2022

Topics this month:

  • Do you know about our ClinicalTrials.gov training?
  • Did You Know? Change is good.
  • Upcoming Changes: Policies are here!
  • New Hires: 
    • Jessica Ordax, Sr. IRB Analyst
    • Kelly Ann Balem, R.N., C.P.N., Sr. Human Research Compliance Specialist

Read the full IRB Newsletter: April 2022 Edition

Special Announcement from the IRB

March 28, 2022

Important Reminder: The Key Information Section

This updated regulatory requirement takes effect next Monday, 4/4/22

Key Information Section Reminder

March 28, 2022

*Important Reminder*
The Key Information Section

This updated regulatory requirement takes effect next Monday, 4/4/22


As stated in our March newsletter, the Key Information Section for Informed Consent Forms will be required as of next Monday, April 4th, 2022! 

The Key Information Section is a part of the Informed Consent Form (ICF) that provides enough information – the “key” information – a prospective participant needs to determine whether they should participate in your study. The Key Information Section is designed to facilitate prospective participants’ (or a legally authorized representative’s) understanding of the research study, and the reasons why one might wish to participate, or not participate, in the study.

Not Receiving Our Newsletter?


The WCM IRB sends out all announcements and updates on the All Protocols and Research Coordinator Network (RCN) listservs. 

  • If you'd like to be added to the All Protocols listsserv, send an email to ALLPROTOCOLS-request@LISTSERV.MED.CORNELL.EDU. In the subject line, type "Subscribe AllProtocols [your first and last name and CWID]"
  • If you'd like to be added to the RCN listserv, send an email to RCN-request@MED.CORNELL.EDU.  In the subject line, type "Subscribe RCN [your first and last name and CWID]"

Weill Cornell Medicine Human Research Protections 575 Lexington Avenue New York, NY 10022 Phone: (646) 962-8200